The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-α

Planta Medica

Volumn 72, Issue 14, 2006, Pages 1279-1284

  Jae, Youl Cho ^a   Eun, Sook Yoo ^b,c   Bae, Cheon Cha ^b,d   Park, Hwa Jin ^e   Man, Hee Rhee ^f   Yong, Nam Han ^g  

^a Kangwon National University   (South Korea)

^b Daewoong Pharmaceutical Co Ltd   (South Korea)

^c Jeju National University School of Medicine   (South Korea)

^d Sangji University   (South Korea)

^e Inje University   (South Korea)

^f Kyungpook National University   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Rosaceae; Sanguisorba officinalis L.; Tissue factor; TNF ; Ziyu glycosides; ZYM 201

Indexed keywords

THROMBOPLASTIN; TRITERPENOID; TRITERPENOID GLYCOSIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYM 201;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLANT ROOT; PROTEIN FUNCTION; RAT; SANGUISORBA; SEPTIC SHOCK;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSIDES; INHIBITORY CONCENTRATION 50; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; SANGUISORBA; THROMBOPLASTIN; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

ROSACEAE; SANGUISORBA OFFICINALIS;

EID: 33845245421     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947257     Document Type: Article

References (20)

1. Broze GJ Jr. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-3
2. Kim I, Oh JL, Ryu YS, So JN, Sessa WC, Walsh K et al. Angiopoietin negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J 2002; 16: 126-8
3. Rao LV, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988; 85: 6687-91
4. Hurlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz 2004; 29: 760-8
5. Dang O, Navarro L, David M. Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes. Shock 2004; 21: 470-5
6. Chu AJ, Walton MA, Prasad JK, Seto A. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells. J Surg Res 1999; 87: 217-24
7. Goun EA, Petrichenko VM, Solodnikov SU, Suhinina TV, Kline MA, Cunningham G et al. Anticancer and antithrombin activity of Russian plants. J Ethnopharmacol 2002; 81: 337-42
8. Liu X, Cui Y, Yu Q, Yu B. Triterpenoids from Sanguisorba officinalis. Phytochemistry 2005; 66: 1671-9
9. Lee MH, Han YN. A new in vitro tissue factor inhibitory triterpene from the fruits of Chaenomeles sinensis. Planta Med 2003; 69: 327-31
10. Han YN, Rhee IK. Changes of tissue factor activity on inflammatory stimulus and aging in rat. Arch Pharm Res 1998; 21: 549-54
11. Cho JY, Park JS, Baik KU, Lee JG, Kim HP, Yoo ES et al. Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis. Pharmacol Res 2004; 49: 423-31
12. Sommeijer DW, Hansen HR, Vano R, Hamulyak K, Vanz AP, Meesters E et al. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes. J Thromb Haemost 2005; 3: 1168-71
13. Gorlach A. Redox regulation of the coagulation cascade. Antioxid Redox Signal 2005; 7: 1398-404
14. Miller DL, Welty-Wolf K, Carraway MS, Ezban M, Ghio A, Suliman H et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 2002; 26: 650-8
15. Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G et al. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci 1997; 811: 191-206
16. Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ et al. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004; 27: 1580-3
17. Cho JY, Park J, Yoo ES, Baik KU, Jung JH, Lee J et al. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells. Planta Med 1998; 64: 594-7
18. Cho JY, Baik KU, Jung JH, Park MH. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol 2000; 398: 399-407
19. Lindmark E, Siegbahn A. Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thromb Res 2002; 108: 77-84
20. Camera M, Giesen PL, Fallon J, Aufiero BM, Taubman M, Tremoli E et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 531-7